Oracion Biogenics Private Limited - Company Profile

It is a pharma private limited company based in Lucknow, Uttar Pradesh, India, established in 2016.
2016 Lucknow, Uttar Pradesh, India Active
Last Updated:
Access Report
About Oracion Biogenics Private Limited

Oracion Biogenics Private Limited, a active private limited company, was established on 31 May 2016 in Lucknow, Uttar Pradesh, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U74999UP2016PTC083681. Registered under ROC Roc Uttar Pradesh I. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.

It upholds a active non-compliant status. Its leadership includes Sumit Agarwal (Director), Pushpa Agarwal (Director). Past directors included Sarit Agarwal. It is based at 538A/18, Triveni Nagar 2, N/A Yogi Nagar Mandir, Lucknow, Uttar Pradesh, 226020.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999UP2016PTC083681

  • Registration Number

    083681

  • Incorporation Date

    31 May 2016

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Uttar Pradesh I

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 9 Year, 9 Months
Company report

Oracion Biogenics Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Oracion Biogenics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Oracion Biogenics Private Limited?
Current Directors
Name Designation Appointment Date Status
Sumit Agarwal Director 31 May 2016 Current
Pushpa Agarwal Director 31 May 2016 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 02 Jun 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Oracion Biogenics.

Enhance accessibility to Oracion Biogenics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Oracion Biogenics revenue growth over time
Oracion Biogenics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Oracion Biogenics?

Unlock access to Oracion Biogenics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Oracion Biogenics?

Unlock and access historical data on people associated with Oracion Biogenics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Oracion Biogenics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oracion Biogenics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Oracion Biogenics
Recent Activity within the Organization
  • Director Appointment

    Progress on Sumit Agarwal was appointed as a Director was appointed as a Director on 31 May 2016 & has been associated with this company since 9 years 9 months . was documented.

  • Director Appointment

    The activity Pushpa Agarwal was appointed as a Director was appointed as a Director on 31 May 2016 & has been associated with this company since 9 years 9 months . was completed.

  • Company Incorporation

    Progress on Oracion Biogenics Private Limited was registered on 31 May 2016 with Roc Uttar Pradesh I & aged 9 years 9 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Oracion Biogenics Private Limited?

The CIN of Oracion Biogenics Private Limited is U74999UP2016PTC083681.

Where is Oracion Biogenics Private Limited headquartered?

Oracion Biogenics Private Limited is headquartered at 538A/18, Triveni Nagar 2, N/A Yogi Nagar Mandir, Lucknow, Uttar Pradesh, 226020.

When was Oracion Biogenics Private Limited incorporated?

Oracion Biogenics Private Limited was incorporated on 31 May 2016.

Who are the current directors of Oracion Biogenics Private Limited?

The current directors of Oracion Biogenics Private Limited are

What is the primary industry of Oracion Biogenics Private Limited?

The primary industry of Oracion Biogenics Private Limited is Pharma.

Is Oracion Biogenics Private Limited a listed company?

Oracion Biogenics Private Limited is unlisted.

What is the capital structure of Oracion Biogenics Private Limited?

The authorized capital of Oracion Biogenics Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.

What is the compliance status of Oracion Biogenics Private Limited?

The compliance status of Oracion Biogenics Private Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available